Biblio Discovery — Demo Discovery Service

5 results for "Alain Chavanieu"

Showing 1–5 · 0.93 seconds · RSS

  1. Journal Article Full text

    Microsecond Dynamics of Fc–CD16a Recognition: Impact of Mutations, Core Fucosylation, and Fc Asymmetry

    Sébastien Estaran; Bernard Hehlen; Alain Chavanieu

    Antibodies, Vol. 15 No. 1 · 2026 · English · DOAJ Scopus

    Background/Objectives: Antibody-dependent cellular cytotoxicity relies on the interaction between the Fc region of immunoglobulin G1 (IgG1) and the CD16a receptor. While removal of core fucosylation on Fc and introduction of the DFTE mutation set (S239D, H268F, S324T, I332E) are known to enhance…

  2. Journal Article

    Fluorescent analogues of BeKm-1 with high and specific activity against the hERG channel

    Lucie Vasseur; Alain Chavanieu; Stéphanie Combemale et al.

    Toxicon: X, Vol. 2 · 2019 · English · DOAJ Scopus

    Peptidic toxins that target specifically mammalian channels and receptors can be found in the venom of animals. These toxins are rarely used directly as tools for biochemical experiments, and need to be modified via the attachment of chemical groups (e.g., radioactive or fluorescent moieties)…

  3. Journal Article Full text

    Functional Characterization of Four Known Cav2.1 Variants Associated with Neurodevelopmental Disorders

    Mathilde Folacci; Sébastien Estaran; Claudine Ménard et al.

    Membranes, Vol. 13 No. 1 · 2023 · English · DOAJ Scopus

    Cav2.1 channels are expressed throughout the brain and are the predominant Ca2+ channels in the Purkinje cells. These cerebellar neurons fire spontaneously, and Cav2.1 channels are involved in the regular pacemaking activity. The loss of precision of the firing pattern of Purkinje cells leads to…

  4. Journal Article Full text

    Generation Using Phage-Display of pH-Dependent Antibodies Against the Tumor-Associated Antigen AXL

    Tristan Mangeat; Célestine Mairaville; Myriam Chentouf et al.

    Antibodies, Vol. 14 No. 4 · 2025 · English · DOAJ Scopus

    Background/Objectives: Tumor-associated antigens are not tumor-specific antigens but proteins that are overexpressed by tumor cells and also weakly expressed at the surface of healthy tissues. Therefore, some side effects are observed when targeted by therapeutic antibodies, a phenomenon named…

  5. Journal Article

    Targeting pregnane X receptor with a potent agonist-based PROTAC to delay colon cancer relapse

    Lucile Bansard; Guillaume Laconde; Vanessa Delfosse et al.

    Oncogenesis, Vol. 14 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Tumor recurrence is frequently attributed to drug-tolerant cancer cells. We previously demonstrated that downregulation of the Pregnane X Receptor (PXR, NR1I2) reduces chemoresistance and prevents colorectal cancer recurrence in xenograft mouse models. However, there is currently a lack of…